000 01769nam a2200325 4500
001 389781
090 _a389781
100 _a20100921d1993 y0pory50 ba
101 _aeng
200 _aU.S. drug threat assessment
_e1993
_eavailability, price, use, and trafficking of drugs
210 _aWashington, DC
_cStrategic Intelligence Section
_d1993
215 _a102 p.
_cil.
_d28 cm
300 _a(DCITE 16-A1).
330 _aAdministrator's message. Executive assessment. Cocaine: availability/price/purity; use; trafficking; miscellaneous. Crack cocaine: availability/price/purity; use; trafficking. Heroin: availability/price/purity; use; trafficking. Cannabis: availability/price/purity; use; trafficking; domestic cultivation/eradication. Methamphetamine: availability/price/purity; use; illicit manufacture; manufacturing methodologies; chemical diversion; manufacturing/distribution organizations; source areas. LSD: availability/price/purity; use; illicit manufacture and trafficking; distribution. PCP: availability/price/purity; use; trafficking and illicit manufacture. Appendix. Distribution.
606 _aPRODUÇÃO DE DROGA
_9321463
606 _aTRÁFICO DE DROGA
_9238858
606 _aCOCAÍNA
_9343373
606 _aHEROÍNA
_9322386
606 _aCRACK
_9343859
606 _aCANNABIS
_946541
606 _aANFETAMINA
_9343626
606 _aLSD
_9345302
606 _aESTADOS UNIDOS
_9334103
710 _aESTADOS UNIDOS
_bDepartment of Justice. Drug Enforcement Administration. [Intelligence Division]. Strategic Intelligence Section.
_9334103
955 _xOferta